Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Dennis Ding is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/14/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 01/22/2025 | CRNX | Buy Now | Crinetics Pharmaceuticals | $29.21 | 88.26% | Dennis Ding16% | → $55 | Upgrade | Hold → Buy | Get Alert |
| 11/08/2024 | IKT | Buy Now | Inhibikase Therapeutics | $2.19 | 265.3% | Dennis Ding16% | → $8 | Initiates | → Buy | Get Alert |
| 09/20/2024 | ASMB | Buy Now | Assembly Biosciences | $9.60 | 264.58% | Dennis Ding16% | $2 → $35 | Upgrade | Hold → Buy | Get Alert |
| 09/06/2024 | FOLD | Buy Now | Amicus Therapeutics | $6.58 | 173.76% | Dennis Ding16% | → $18 | Initiates | → Buy | Get Alert |
| 09/05/2024 | ABUS | Buy Now | Arbutus Biopharma | $3.19 | 119.78% | Dennis Ding16% | $5 → $7 | Maintains | Buy | Get Alert |
| 09/03/2024 | RXRX | Buy Now | Recursion Pharmaceuticals | $5.61 | 6.95% | Dennis Ding16% | $8 → $6 | Maintains | Hold | Get Alert |
| 05/07/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.11 | 369.92% | Dennis Ding16% | $10 → $0.5 | Downgrade | Buy → Hold | Get Alert |
| 06/27/2023 | CARA | Buy Now | Cara Therapeutics | $5.01 | 259.28% | Dennis Ding16% | → $216 | Reiterates | Buy → Buy | Get Alert |
| 02/15/2023 | CORT | Buy Now | Corcept Therapeutics | $69.74 | -68.45% | Dennis Ding16% | $35 → $22 | Downgrade | Buy → Hold | Get Alert |
| 12/19/2022 | NAMS | Buy Now | NewAmsterdam Pharma | $15.26 | 57.27% | Dennis Ding16% | → $24 | Initiates | → Buy | Get Alert |
| 10/17/2022 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | Dennis Ding16% | — | Downgrade | Buy → Hold | Get Alert |
| 07/20/2022 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | Dennis Ding16% | → $25 | Initiates | → Buy | Get Alert |
| 02/02/2022 | ABUS | Buy Now | Arbutus Biopharma | $3.19 | 56.99% | Dennis Ding16% | $4 → $5 | Upgrade | Hold → Buy | Get Alert |
| 02/01/2022 | CINC | Buy Now | CinCor Pharma | — | — | Dennis Ding16% | → $30 | Initiates | → Buy | Get Alert |
| 01/18/2022 | PRDS | Buy Now | Pardes Biosciences | — | — | Dennis Ding16% | → $25 | Initiates | → Buy | Get Alert |
| 11/30/2021 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Dennis Ding16% | $195 → $52 | Downgrade | Buy → Hold | Get Alert |
| 10/26/2021 | ROIV | Buy Now | Roivant Sciences | $9.97 | 0.3% | Dennis Ding16% | → $10 | Initiates | → Buy | Get Alert |
| 12/29/2020 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Dennis Ding16% | → $780 | Initiates | → Buy | Get Alert |
